JCMVX | MVCAX | JCMVX / MVCAX | |
Total Expense Ratio | 1.59 | 0.99 | 161% |
Annual Report Gross Expense Ratio | 1.70 | 1.00 | 170% |
Fund Existence | 24 years | 24 years | - |
Gain YTD | 1.910 | 3.325 | 57% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.4B | 17.1B | 73% |
Annual Yield % from dividends | 0.14 | 0.86 | 16% |
Returns for 1 year | -4.90 | -3.52 | 139% |
Returns for 3 years | -9.26 | 6.81 | -136% |
Returns for 5 years | 5.57 | 47.65 | 12% |
Returns for 10 years | -6.18 | 63.09 | -10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PQJL | 27.66 | 0.25 | +0.91% |
PGIM NASDAQ-100 BUFFER 12 ETF - JULY | |||
HELX | 29.58 | 0.21 | +0.73% |
Franklin Genomic Advancements ETF | |||
IDOG | 36.00 | 0.23 | +0.64% |
ALPS International Sector Div Dogs ETF | |||
FAAR | 28.92 | 0.02 | +0.06% |
First Trust Alt Abs Ret Strat ETF | |||
SECT | 60.05 | -0.22 | -0.37% |
Main Sector Rotation ETF |